Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study
Leuk Lymphoma
.
2022 Jun;63(6):1504-1507.
doi: 10.1080/10428194.2022.2027403.
Epub 2022 Jan 24.
Authors
Simone Claudiani
1
,
Eleanor L Parker
2
,
Dragana Milojkovic
1
,
Carolina Rosadas
2
,
Afzal Khan
1
,
Ksenia Katsanovskaja
2
,
Federica Marchesin
2
,
Maryam Khan
2
,
Richard S Tedder
2
,
Andrew J Innes
1
,
Myra O McClure
2
,
Jane F Apperley
1
Affiliations
1
Department of Immunology and Inflammation, Faculty of Medicine, Centre for Haematology, Hammersmith Campus, Imperial College London, London, UK.
2
Department of Infectious Disease, Faculty of Medicine, St Mary's Campus, Imperial College London, London, UK.
PMID:
35068289
DOI:
10.1080/10428194.2022.2027403
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Viral
COVID-19* / epidemiology
Humans
Immunoglobulin G
SARS-CoV-2
Seroepidemiologic Studies
Substances
Antibodies, Viral
Immunoglobulin G